StemBioSys

StemBioSys

The Next Evolution in Cell Culture

Print
Claim My Business
Form C
View on StartEngine
Min Investment
$300
Location
San Antonio , TX
Expected Close Date
September 03, 2024
Target Raise
$15.00K-$3.00M
Security Price
$3
Website
stembiosys.com
Number of Employees
9
Cash
$111,047
Revenue
$550,450
Short Term Debt
$1,586,281
Cost of Goods
$0
Long Term Debt
$405,497
Net Income
$-1,537,261

Company Description

StemBioSys® is a biomedical company whose advanced cell technologies can test drugs more efficiently and accurately without using animal models.

Key Deal Facts

StemBioSys® innovates drug testing with patented lab tools allowing the testing of new products with cultured human cells, not from embryos, replacing less accurate chemical tests & experimental animal models.

StemBioSys® has established a strong foothold in the biopharmaceutical, academic, and government markets with pioneering products such as CELLvo™ Atrial Cardiomyocytes and our patented Matrix Plus™.
Amount Raised : $70,902
Reveal the Score by Voting
＿
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
ⓘ
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
ⓘ
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
ⓘ
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
ⓘ
The value of the company compared to similar companies raising money from investors.
Valuation

Research Reports

No reports have been submitted

Become a Reporter
Read Our Research Disclaimer

0 Comments

Post Comment